The landscape of pharmaceutical manufacturing and quality control is seeing a key change with crucial updates to the United States Pharmacopeia (USP) standards for container closure systems. As the deadline on December 1st, 2025, draws near, the industry must prepare to adapt to the new container closure requirements set forth by the USP. This article will give a comprehensive overview of the evolving container closure requirements for parenteral products and insightful exploration of the alterations introduced by USP <661.1>, <661.2>, and, <382> equipping pharmaceutical manufacturers with the essential knowledge to navigate the evolving regulatory compliance standards effectively. Download now to learn more.